Humana (NYSE:HUM) Issues FY 2024 Earnings Guidance

Humana (NYSE:HUM) updated its FY 2024 earnings guidance on Monday. The company provided EPS guidance of 16.000-16.000 for the period, compared to the consensus EPS estimate of 16.360. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on HUM. The Goldman Sachs Group lowered their price target on shares of Humana from $450.00 to $385.00 and set a buy rating on the stock in a report on Wednesday, April 3rd. Oppenheimer reduced their price target on shares of Humana from $415.00 to $370.00 and set an outperform rating on the stock in a report on Thursday, April 25th. Raymond James initiated coverage on Humana in a report on Friday, March 22nd. They issued a market perform rating on the stock. UBS Group dropped their price target on Humana from $334.00 to $326.00 and set a neutral rating for the company in a research note on Thursday, April 25th. Finally, Argus downgraded Humana from a buy rating to a hold rating in a research note on Wednesday, March 13th. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of Hold and an average price target of $423.63.

Humana Price Performance

HUM opened at $355.48 on Monday. The business has a fifty day moving average of $340.05 and a 200 day moving average of $354.76. Humana has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock has a market cap of $42.84 billion, a P/E ratio of 22.13, a PEG ratio of 2.09 and a beta of 0.53.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period in the prior year, the business earned $9.38 EPS. As a group, sell-side analysts anticipate that Humana will post 16.07 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.